Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by OLIVARESJorge Juárez of Olivares explains the requirements for applicants aiming to protect industrial designs in designating Mexico and highlights the importance of compliance with the unity of design requirement
-
Sponsored by Remfry & SagarV Mohini and Sonal Goel of Remfry & Sagar say that the Indian courts are sending an increasingly clear message regarding the awarding of damages for the victims of IP crimes
-
Sponsored by ZaccoIn the first article of a four-part series, IP experts from across Zacco explore some of the issues that are frequently raised by companies, beginning with addressing some of the complexities of entering the European market from abroad and explaining what approaches could be taken
-
Sponsored by Maiwald Intellectual PropertyA shift is required in the finance and banking sectors’ approach to the use of intangible capital assets as collateral, says Marco Stief of Maiwald
-
Sponsored by Bird & BirdLorraine Tay, Gene Kwek, and Randy Hong of Bird & Bird ATMD report on a decision by the Singapore Trademarks Registry that accepted evidence of use based on consumers’ online posts
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkin, Selin Sinem Erciyas, and Aysu Eryaşar of Gün + Partners report that the highly debated concept of plausibility is gaining prominence in Turkish invalidity proceedings